The Board of Endonovo Therapeutics, Inc. (OTCPK:ENDV) announced the spin off of Medical Device Division of Endonovo Therapeutics on January 9, 2023. It is expected that approximately 20% of the shares received in the spin-off will be paid to satisfy its existing debtholders with the balance principally available to existing shareholders. The planned spin-off of SofPulse, Inc. is expected to be completed later in 2023.

Ocean Tomo, LLC acted as fairness opinion provider to Endonovo Therapeutics, Inc.